We're currently experiencing extremely high call volumes. We're very sorry for any inconvenience this might cause. If you need help with your account, please visit our Help Centre, or email us and we’ll get back to you as soon as we can. For more information and tips on managing your account online please visit www.hl.co.uk/coronavirus

We’re experiencing high call volumes, please check FAQs before calling.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Covetrus Inc (CVET) NPV

Sell:$8.36 Buy:$8.40 Change: $0.89 (11.85%)
Market closed |  Prices as at close on 9 April 2020 | Switch to live prices |
Change: $0.89 (11.85%)
Market closed |  Prices as at close on 9 April 2020 | Switch to live prices |
Change: $0.89 (11.85%)
Market closed |  Prices as at close on 9 April 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Covetrus, Inc. is a global animal-health technology and services company. The Company provides service and technology platform to animal veterinary markets. It combines practice management software, prescription management, multi-channel client engagement services and supply chain infrastructure to promote connectivity between veterinarians and clients. The Company is also focused on providing inventory management, specialty pharmacy services, solutions to chronic care disease management, veterinary practice management software and client communication tools.

Contact details

7 Custom House St
United States
+1 (631) 8435500

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$939.56 million
Shares in issue:
111.85 million
Health Care Distributors
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Philip Laskawy
    Chairman of the Board
  • Benjamin Wolin
    President, Chief Executive Officer, Director
  • Stuart Gleichenhaus
    Interim Chief Financial Officer
  • James Young
    Chief Human Resource Officer, Senior Vice President
  • Erin Brennan
    Senior Vice President, General Counsel, Secretary
  • Russell Cooke
    Senior Vice President and Operational Chief Financial Officer
  • Michael Ellis
    Senior Vice President and President - Europe
  • David Hinton
    Senior Vice President and President - APAC and Emerging Markets
  • Timothy Ludlow
    Senior Vice President and Chief Transformation Officer
  • Anthony Providenti
    Senior Vice President, Corporate Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.